The NFL Alumni Association and Cancer Treatment Centers of America Team Up Against Prostate Cancer

TThe NFL Alumni Association and the Cancer Treatment Centers of America have teamed up with LabCorp to educate men about prostate cancer and to encourage them to get screened. One out of seven men, (one out of five African American men) are diagnosed with prostate cancer during their lifetime.

If caught early, prostate cancer can be controlled and eliminated. If cancer spreads, however it can be deadly. Men can receive a discounted price of $25 for screening and it can be done at LabCorps which has medical facilities all over the United States.

The Cancer Treatment Centers of America is a well-known medical facility that specializes in cancer treatment. They not only use the traditional methods of treatment such as surgery, radiation, and chemotherapy, but they use many other natural methods as well. They treat the whole person and cater to family needs as well.

The program for prostate cancer screening is called the “Prostate Pep Talk” and features former NFL coaches Herm Edwards, Dick Vermeil and Bill Cowher who will be encouraging men to get a screening test as soon as possible. They point out that just about everyone knows someone who has had to battle prostate cancer, and many know someone who has lost the battle.

Cancer Treatment Centers of America has full-fledged treatment centers located in Atlanta, Chicago, Phoenix, Tulsa, and Philadelphia. Cancer Treatment Centers of America only treats cancer and nothing else. They have found that specializing in cancer only has enhanced the focus on the battle against cancer. They diagnose and treat all kind of cancer and their research facilities are constantly coming up with new treatments against the disease.

Called the integrated approach, their multifaceted treatment uses all possible resources in the fight against cancer. The treatment is accomplished all under one roof so the patients and families don’t have to go to many different places for their treatment.

To Learn More Click Here

Dr. David Samadi meets with Dr. Cynara Cooper in Housecall

Dr. David Samadi is an executive at the Lenox Hill Hospital and heads the Urology. He is the head of the robotic surgery at the hospital. He is a certified specialist in the field of Urology oncology, and he has experience in the open traditional and Laparoscopic Surgery. Additionally, he does the robotic prostate surgery. As one of the top surgeon in the country, he has dedicated his expertise to conducting early diagnosis and early treatment to prostrate cancer. His major job is to make the world aware of the disease as the second disease that is fatal to men.

Dr. Samadi is expected to hold a meeting with Dr. Cynara Coomer in an interview in the famous television program, The Dr. Samedi’s weekly interview Housecall. Dr. Coomer works as the chief in breast surgery in the North Well health Staten Island University Hospital. Dr. Cooper is also the director of the comprehensive breast center at the university.

Considering that October is the world’s cancer awareness month, Dr. Samedi’s saw it good to have Dr. Coomer in the interview. Dr. Coomer is the first individual catalyst towards the establishment of the world’s first comprehensive Breast Center that is located at the Staten Island. Dr. Coomer is known well as the one of the most esteemed staff of the Lenox Hill Hospital and as the topmost expert in the breast health in the hospital.

Dr. Coomer initially worked at Mount Sinai Medical Center in the New York as a breast surgeon before joining the North Health Staten Island University Hospital. While here, she managed to develop a clinical practice that was basically for the treatment of both the breast diseases-benign and malignant diseases. Dr. Samadi expresses his joy in joining again with Dr. Coomer in the significant interview that will also touch on breast awareness. She continues to express gratitude favor joining with Dr. Samadi in the interview that is meant to educate the entire population in America on the importance of medical attention to the breast and prostate diseases.

Dr. Samadi was born to a Persian Jewish family in Iran. The Iranian revolution forced him and his brother to leave Iran. He was only 15 by then. He continued his education in Belgium and London. Afterwards, he joined Roslyn high school in New York. He was awarded a full scholarship that took him to the university degree in biochemistry at the Stony Brook University. Afterwards, he attained a master’s degree from the same university in 1994.

For details: about.me/dr.davidsamadi/

Mikhail Blagosklonny Revolutionizes Cancer Therapies and the Aging Process in Humans

Dr. Mikhail Blagosklonny is an oncology Professor at Roswell Park Institute of Cancer; New York. He is also a cancer scientist specialized in the aging and cancer studies. Blagosklonny is an M.D., Ph.D. graduate in Cardiology/Medicine from the Medical University; Pavlov, St. Petersburg. He was selected as a Medicine Professor at the College of Medicine; New York in 2002.

Dr. Blagoskonny was also a scientist at the O.R Institute in Albany; New York. He was confirmed in 2009 as an Oncology Professor at the prestigious Cancer Institute; Roswell Park. Dr. Blagosklonny’s research focuses on possible cancer remedies and the principal methods of growing old and anti-age medication.

Cancer Aging and Rapamycin

Mikhail Blagosklonny created a hypothesis focusing on TOR signals role in cancer and aging as well as the proposed rapamycin, an accepted cancer medicine, a promising treatment therapy for the extension of life. Blagosklonny is Chief Editor of the Aging Cell Cycle and Oncotarget as well as the Editorial Associate of Cancer Therapy and Biology. He also serves on the Cell Death Editorial Board.

Mikhail’s role at the Roswell Park Cancer Institute

Mikhail Blagosklonny was appointed as an Associate Professor of Oncology at the Roswell Park Cancer Institute on April 15, 2009. Misha is a paramount researcher in the development of cancer concepts in biology and therapy. His presence at Roswell Park facilitates the advancement of innovative anti-cancer stratagem and cancer treatment and prevention methods.

Blagosklonny’s Hypothesis about the Possible Role of TOR Signaling in Aging and Cancer
Aging is understood from the evolution point of view on LinkedIn. Organisms in the wild do not live long to experience aging. Therefore only in the protected environment do humans and domestic animals die from aging.

The TOR nutrient-sensing pathway is triggered by nutrients, insulin, and growth factors on Google. In turn, it increases protein synthesis, stimulates cell mass growth and, induces buildup of growth proteins, and causes resistance to insulin and GF.

In short, TOR causes cell hyper-functions to each particular tissue such as bone by soft muscle cells, and visible osteoporosis. This ultimately damages organs (aging- disaster) leading to age-related illnesses. The TOR passage is implicated in diseases like cancers, diabetes type II, age-related muscular degeneration, organ failure (liver, renal and cardiac), Alzheimer’s and arthritis.

The theory that aging isn’t motivated by the accumulation of accidental damage best explains hormesis. Category A Hormesis upsets the TOR pathway. Category B Hormesis cause damaging anxiety. Aging is not brought about by loss, but it may cause the acceptance of aging, therefore protecting humans from dangerous aging-induced disasters.